11. April 2019 - Preliminary IFRS result 2018

investor news

MPH Health Care AG: Preliminary IFRS result 2018

2018: Net income 37.03 million euro, earnings per share 0.87 euro (previous year 31.86 million euro, earnings per share 0.74 euro). The net asset value was euro 6.29 per share (previous year euro 5.62).

Berlin, April 11, 2019: Preliminary IFRS result: MPH Health Care AG, Berlin (ISIN: DE000A0L1H32), announces preliminary IFRS consolidated result for fiscal year 2018. In the 2018 financial year, the preliminary IFRS net income amounted to 37.03 million euro (0.87 euro earnings per share).

HAEMATO AG, M1 Kliniken AG and CR Capital Real Estate AG, which are listed on the Frankfurt Stock Exchange, continued to operate successfully in the 2018 financial year.

HAEMATO AG was able to achieve consolidated sales of 274.1 million euro, an EBITDA of 10.0 million euro and a net profit of 6.3 million euro (according to IFRS 15). The improvement in operating gross profit was just under 1 %. Financial liabilities were reduced significantly by a total of euro 10.9 million, based on the cancellation of the profit participation certificates. The Management Board has announced that the Supervisory Board will propose an unchanged dividend of 30 cents per share for the 2018 financial year.

M1 Kliniken AG was able to increase the number of treatments performed in the past financial year to almost 190,000, further extending its market leadership. A key element here is the further increase in the number of M1 specialist centres from 17 (as 31.12.2017) to 24 (as 31.12.2018). The international expansion was initiated with the first M1 specialist centre in Vienna. In 2018, the product range was expanded to include aesthetic dental and laser treatments with M1 Dental and M1 Laser. The continuation of the expansion to a total of 50 specialist centres is planned for 2020.

The M1 share price rose from euro 13.20 on January 2, 2018 to euro 15.00 on December 31, 2018. In September 2018, the share capital was increased by € 1,000,000.00 to euro 17,500,000.00 by means of a capital increase through the issue of a total of 1,000,000 bearer shares. The dividend paid in June 2018 amounted to 30 cents per share.

CR Capital Real Estate AG was again able to significantly increase its net profit for the 2018 financial year by 33% to euro 7.7 million, whitch is euro 1.9 million above the previous year’s result of euro 5.8 million. Sales increased by +123% to euro 23.2 million, earnings per share by +30% to euro 4.10 (previous year euro 3.14). The share price of CR Capital Real Estate AG increased from euro 20.80 on January 2, 2018 to euro 32.60 on December 31, 2018. Due to the extremely positive result, the Management Board proposes to increase the dividend for the 2018 financial year and to issue bonus shares, which would be fully entitled to dividends from the 2019 financial year onwards.

“We are confident about the further development in 2019. Since 2005, the healthcare industry has expanded its gross value added more strongly than the economy as a whole every year. MPH benefits systematically from the growth of HAEMATO AG with drugs in the insurance-financed market and M1 Kliniken AG in the private payer market, the so-called second health market. This is also reflected in the comparison of the share price performance with the SDAX.

In recent years, a dividend of 12 cents has been distributed, and for the 2017 financial year a dividend of 20 cents per share has been distributed. Due to the continuing positive results of recent years, we will again propose a dividend of 20 cents per share for 2018 at the Annual General Meeting,” said Patrick Brenske, CEO of MPH.